Cite
APA Citation
King, A. C., Peterson, T. J., Horvat, T. Z., Rodriguez, M., & Tang, L. A. (n.d.). venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies. Annals of pharmacotherapy, 51, 410–416. http://access.bl.uk/ark:/81055/vdc_100068719755.0x00000c